封面
市場調查報告書
商品編碼
2058434

泰樂菌素市場:依藥物類型、應用、給藥途徑及地區分類

Tylosin Market, By Drug Type, By Application, By Route of Administration, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 250 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2026 年,酪胺酸市場價值將達到 8.3 億美元,到 2033 年將達到 11.2 億美元。預計從 2026 年到 2033 年,其複合年成長率將達到 4.34%。

報告範圍 報告詳情
基準年: 2025 2026年市場規模: 8.3億美元
歷史數據時期: 2020年至2024年 預測期: 2026年至2033年
2026年至2033年預測期間的複合年成長率: 4.34% 2033年市場規模預測: 11.2億美元

泰樂菌素在畜牧業中用途廣泛,包括作為飼料添加劑促進生長,以及作為抗生素治療雞、火雞、貓、狗、豬和牛等動物的感染疾病。這些抗生素可用於治療慢性呼吸道疾病(CRD)以及與黴漿菌支原體和黴漿菌支原體相關的其他感染疾病。

泰樂菌素用於治療和控制由豬痢疾螺旋體引起的豬痢疾,以及控制豬的增生性腸道疾病。此外,泰樂菌素對犬的泰樂菌素敏感性腹瀉也十分有效,這種腹瀉是一種慢性複發性腹瀉,對泰樂菌素治療反覆有效。

市場動態

由於畜牧業對泰樂菌素的需求不斷成長,預計全球泰樂菌素市場在預測期內將顯著成長。例如,根據紐西蘭一級產業部2016年的一項調查,2011年至2014年間,泰樂菌素佔大環內酯類和林可醯胺類抗生素銷售額的83%以上,預計這一趨勢在預測期內將持續維持。

此外,預計某些併購活動將在預測期內推動市場成長。例如,禮來公司於2014年收購了諾華動物保健公司。來自禮來動物保健公司等製造商的多元化產品線預計將在預測期內推動全球泰樂菌素市場的成長。例如,禮來公司提供「含泰樂菌素的組件」植入產品線,其中包括用於去勢牛和牛的早期和最終植入。這些植入含有酒石酸泰樂菌素(泰樂菌素)顆粒,這些顆粒會在植入部位溶解並釋放抗菌成分。

本次調查的主要特點

  • 本研究確定了各個細分市場的潛在商機,並說明了該市場具有吸引力的投資提案矩陣。
  • 此外,本研究還深入分析了市場促進因素、限制因素、機會、新應用推出和核准、區域展望以及主要參與者採取的競爭策略。
  • 本研究根據以下參數對全球酪胺酸市場的主要參與者進行了分析:公司概況、財務績效、產品系列、地理分佈、分銷策略、關鍵發展和策略。
  • 透過利用本報告中的見解,企業行銷負責人和經營團隊可以就未來的產品推出、技術升級、市場擴張和行銷策略做出明智的決策。
  • 這份全球泰樂菌素市場報告旨在為行業內的各種相關人員提供參考,包括投資者、供應商、製藥商、經銷商、新參與企業和金融分析師。
  • 透過用於分析酪胺酸市場的各種策略矩陣,相關人員將能夠更輕鬆地做出決策。

目錄

第1章:研究目標與前提條件

  • 分析目的
  • 先決條件
  • 簡稱

第2章 市場概覽

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章:市場動態、監管與趨勢分析

  • 市場動態
    • 促進因素
    • 抑制因子
    • 市場機遇
  • 影響分析
  • 市場趨勢
  • 主要進展
  • 產品核准
  • 合作關係、併購
  • 監理情勢
  • PEST分析
  • 波特五力分析
  • 流行病學
  • 穩健的管道分析

第4章 全球泰樂菌素市場:依藥物類型分類,2021-2033年

  • 磷酸泰樂菌素
  • 酒石酸泰樂菌素
  • 其他

第5章 全球泰樂菌素市場:依應用領域分類,2021-2033年

  • 貓科動物
  • 家畜

第6章 全球泰樂菌素市場:依給藥途徑分類,2021-2033年

  • 口服
  • 注射藥物

第7章 全球泰樂菌素市場:依地區分類,2021-2033年

  • 北美洲
    • 美國
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲國家
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 法國
    • 西班牙
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • ASEAN
    • 澳洲
    • 韓國
    • 其他亞太國家
  • 中東
    • GCC
    • 以色列
    • 其他中東國家
  • 非洲
    • 北非
    • 中非
    • 南非

第8章 競爭情勢

  • 熱圖分析
  • 市佔率分析
  • 公司簡介
    • Zoetis
    • Tairui Pharmaceuticals
    • Lukang Pharmaceutical
    • Henan Hualun
    • Qilu Pharmaceutical(Inner Mongolia)Co., Ltd,
    • Huvepharma
    • AdvaCare Pharma
    • Elanco Animal Health

第9章

  • 參考
  • 調查方法
  • 關於本公司
簡介目錄
Product Code: CMI2061

Tylosin Market is estimated to be valued at USD 830 Mn in 2026 and is expected to reach USD 1,120 Mn by 2033, growing at a compound annual growth rate (CAGR) of 4.34% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 830 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 4.34% 2033 Value Projection: USD 1,120 Mn

Tylosin is used in livestock for various purposes such as a feed additive for growth promotion and as an antibiotic against infectious diseases in animals such as chickens, turkeys, felines, canines, pigs, calves, and others. These antibiotics aid in the treatment of chronic respiratory disease (CRD) associated with Mycoplasma Gallisepticum and Mycolplasma synoviae and other infections.

Tylosin is used for treatment and control of swine dysentery associated with Brachyspira Hyodysenteriae and for the control of porcine proliferate enteropathies in pigs. Moreover, Tylosin is highly effective in tylosin-responsive diarrhea in dogs, which is a canine chronic, recurrent diarrhea that responds repeatedly to Tylosin treatment.

Market Dynamics

The global Tylosin market is expected to witness significant growth over the forecast period, owing to rising demand for Tylosin in livestock industry. For instance, according to a study by Ministry for Primary Industries, New Zealand 2016, Tylosin accounted for over 83% of macrolide and lincosamide sales during 2011 and 2014 and the trend is expected to continue over the forecast period.

Moreover, certain mergers and acquisitions are expected to boost the market growth over the forecast period. For instance, Eily, Lilly, and Company acquired Novartis Animal Health in 2014. Varied product offering by manufacturers such as Elanco Animal Health is expected to propel the global Tylosin market growth over the forecast period. For instance, Elanco offers Component with Tylan, an implant line with initial and terminal implants for steers and heifers. This implant includes a tylosin tartrate (Tylan) pellet that dissolves and releases antibacterial throughout the implant site.

Key features of the study

  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new application launches or approval, regional outlook, and competitive strategy adopted by the leading players
  • It profiles leading players in the global tylosin market based on the following parameters - company overview, financial performance, application portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key companies covered as a part of this study include, Zoetis, Tairui Pharmaceuticals, Lukang Pharmaceutical, Henan Hualun, Qilu Pharmaceutical (Inner Mongolia) Co., Ltd, Huvepharma, AdvaCare Pharma, and Elanco Animal Health
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future application launches, technology up-gradation, market expansion, and marketing tactics
  • The global Tylosin market report caters to various stakeholders in this industry including investors, suppliers, application manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the Tylosin market

Market Segmentation

  • By Drug Type (Revenue, USD Mn, 2021-2033)
    • Tylosin Phosphate
    • Tylosin Tartrate
    • Others
  • By Application (Revenue, USD Mn, 2021-2033)
    • Felines
    • Canines
    • Livestock
  • By Route of Administration (Revenue, USD Mn, 2021-2033)
    • Oral
    • Injectable
  • By Region (Revenue, USD Mn, 2021-2033)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • Central Africa
    • North Africa
  • Key Players
    • Zoetis
    • Tairui Pharmaceuticals
    • Lukang Pharmaceutical
    • Henan Hualun
    • Qilu Pharmaceutical (Inner Mongolia) Co., Ltd
    • Huvepharma
    • AdvaCare Pharma
    • Elanco Animal Health

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Overview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Drug Type
    • Market Snapshot, By Application
    • Market Snapshot, By Route of Administration
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Product Approval
  • Collaboration/Merge/Acquisition
  • Regulatory Landscape
  • PEST Analysis
  • Porter's Five Forces Analysis
  • Epidemiology
  • Robust Pipeline Analysis

4. Global Tylosin Market, By Drug Type, 2021 - 2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022- 2033
    • Segment Trends
  • Tylosin Phosphate
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Tylosin Tartrate
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

5. Global Tylosin Market, By Application, 2021 - 2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022- 2033
    • Segment Trends
  • Felines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Canines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Livestock
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

6. Global Tylosin Market, By Route of Administration, 2021 - 2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022- 2033
    • Segment Trends
  • Oral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Injectable
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

7. Global Tylosin Market, By Region, 2021 - 2033, (USD Mn)

  • Introduction
    • Market Share Analysis, By Region, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, For Regions, 2022-2033
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Mn)
      • North Africa
      • Central Africa
      • South Africa

8. Competitive Landscape

  • Heat Map Analysis
  • Market Share Analysis
  • Company Profile
    • Zoetis
      • Company Highlights
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Market Strategies
    • Tairui Pharmaceuticals
      • Company Highlights
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Market Strategies
    • Lukang Pharmaceutical
      • Company Highlights
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Market Strategies
    • Henan Hualun
      • Company Highlights
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Market Strategies
    • Qilu Pharmaceutical (Inner Mongolia) Co., Ltd,
      • Company Highlights
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Market Strategies
    • Huvepharma
      • Company Highlights
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Market Strategies
    • AdvaCare Pharma
      • Company Highlights
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Market Strategies
    • Elanco Animal Health
      • Company Highlights
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Market Strategies
      • Analyst Views

9. Section

  • References
  • Research Methodology
  • About Us